Boston Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-79,947
| Closed | -$2.3M | – | 671 |
|
|
2018
Q3 | $2.3M | Sell |
79,947
-119,337
| -60% | -$3.43M | 0.1% | 260 |
|
|
2018
Q2 | $5.43M | Buy |
199,284
+58,727
| +42% | +$1.6M | 0.14% | 162 |
|
|
2018
Q1 | $3.14M | Sell |
140,557
-62,453
| -31% | -$1.4M | 0.08% | 237 |
|
|
2017
Q4 | $4.28M | Sell |
203,010
-5,880
| -3% | -$124K | 0.09% | 235 |
|
|
2017
Q3 | $5.2M | Sell |
208,890
-10,275
| -5% | -$256K | 0.12% | 206 |
|
|
2017
Q2 | $4.25M | Sell |
219,165
-10,840
| -5% | -$210K | 0.1% | 228 |
|
|
2017
Q1 | $4.25M | Buy |
230,005
+45,050
| +24% | +$832K | 0.1% | 233 |
|
|
2016
Q4 | $3.5M | Sell |
184,955
-33,370
| -15% | -$632K | 0.08% | 259 |
|
|
2016
Q3 | $4.89M | Buy |
218,325
+191,380
| +710% | +$4.28M | 0.12% | 204 |
|
|
2016
Q2 | $480K | Buy |
26,945
+5,185
| +24% | +$92.4K | 0.01% | 492 |
|
|
2016
Q1 | $297K | Sell |
21,760
-420
| -2% | -$5.73K | 0.01% | 589 |
|
|
2015
Q4 | $428K | Buy |
+22,180
| New | +$428K | 0.01% | 499 |
|